Thirty-Day Readmissions After Cardiac Implantable Electronic Devices in the United States: Insights from the Nationwide Readmissions Database.

Abstract

BACKGROUND: Limited data are available regarding true estimates of individual complications contributing to readmissions after cardiac implantable electronic device (CIED) implantation. OBJECTIVE: We aimed to identify predictors of 30-day readmission in patients admitted for CIED implantation. METHODS: The study cohort consisted of patients who received CIED implantation in 2014, identified from National Readmission Database. Readmission was defined as a subsequent hospital admission within 30 days after discharge day of index admission. If patients had more than one readmission within 30 days, only the first readmission was included. RESULTS: Our final cohort consisted of 70,223 cases, of which 61,738 (88%) in no-readmission and 8,485 patients (12%) in readmission group. Female gender (OR 1.09, 95%CI: 1.04-1.14; p=0.001), atrial fibrillation/flutter (OR 1.23, 95%CI: 1.17-1.29, p CONCLUSION: Several patient and hospital-related factors were identified to be independent predictors of 30-day readmission, accounting for increased healthcare cost

    Similar works